September 10, 2026
Three separate acquisition announcements drew selloffs in the acquirers' stocks, including Meta dropping 1.6 percent.
What happened
Meta said it is buying Swedish AI startup Stilla.ai, Revvity struck a deal for Human Cell Design, and Forward Industries confirmed it rejected a buyout offer at a 20 percent premium. All three acquirers fell on the news. Meta dropped 1.6 percent, a move bigger than 62 percent of its days over the past three years, while Revvity fell 2.2 percent, a larger move than 75 percent of its recent days.
Why it matters
Acquisition announcements typically pressure the buyer's shares as investors worry about the price paid and integration risk, even while the market's overall trend remains constructive. Meta's AI deal signals that large tech firms are willing to spend on artificial intelligence capabilities despite the immediate stock hit. A wave of dealmaking across tech, life sciences, and industry shows confidence in future growth but punishes the acquirers in the short term.
The case against
These selloffs may be temporary and driven by mechanical hedging rather than a verdict on the deals themselves. Meta's AI infrastructure spending could unlock significant revenue if demand materializes, and Forward Industries' board rejection of what it called a lowball bid suggests discipline that might reward shareholders later.
Our read
Investment in AI compute buildout will continue to drive growth over the next 2 to 3 years as companies increase capital expenditures to support AI infrastructure, which makes Meta's move consistent with our view even though the stock dipped on the announcement.
What settles it
Whether Meta and Revvity shares recover their deal-day losses within a month, which would signal that investors ultimately support the M&A logic.